Cemdisiran (sodium)
Cemdisiran sodium is an N-acetylgalactosamine (GalNAc) conjugated siRNA for the research of complement-mediated diseases by suppressing liver production of complement 5 (C5) protein.
Product Specifications
Product Name Alternative
ALN-CC5 (sodium)
UNSPSC
12352208
Target
Complement System
Type
Oligonucleotides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/cemdisiran-sodium.html
Purity
96.30
Solubility
10 mM in H2O
Smiles
[Cemdisiran(sodium)]
Molecular Formula
C542H665F17N169Na46O330P45S6
Molecular Weight
16782.66 (free acid)
References & Citations
[1]Badri P, Jiang X, Borodovsky A, et al. Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria. Clin Pharmacokinet. 2021;60 (3) :365-378.|[2]Prajakta Badri, et al. Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria. Clin Pharmacokinet. 2021;60 (3) :365-378.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB1813-500 1x 500 µL
MTAP (Tumor Suppressor Marker) (MTAP/1813), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
